CAS 88-68-6|Anthranilamide
Introduction：Basic information about CAS 88-68-6|Anthranilamide, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Anthranilamide | ||
|---|---|---|---|
| CAS Number | 88-68-6 | Molecular Weight | 136.151 |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 300.9±15.0 °C at 760 mmHg |
| Molecular Formula | C7H8N2O | Melting Point | 111-113 °C(lit.) |
| MSDS | ChineseUSA | Flash Point | 135.8±20.4 °C |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | 2-Aminobenzamide |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 300.9±15.0 °C at 760 mmHg |
| Melting Point | 111-113 °C(lit.) |
| Molecular Formula | C7H8N2O |
| Molecular Weight | 136.151 |
| Flash Point | 135.8±20.4 °C |
| Exact Mass | 136.063660 |
| PSA | 69.11000 |
| LogP | 0.45 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.633 |
| InChIKey | PXBFMLJZNCDSMP-UHFFFAOYSA-N |
| SMILES | NC(=O)c1ccccc1N |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- >400 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- CHTPBA Chimica Therapeutica. (Paris, France) V.1-8, 1965-73. For publisher information, see EJMCA5. Volume(issue)/page/year: 2,202,1967
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Bird - wild bird species
- DOSE/DURATION :
- 1 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- AECTCV Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973- Volume(issue)/page/year: 12,355,1983
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H315-H317-H319-H335 |
| Precautionary Statements | P261-P280-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| Hazard Codes | Xn:Harmful |
| Risk Phrases | R22;R36/37/38;R43 |
| Safety Phrases | S26-S36/37 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 1 |
| RTECS | CU8993000 |
| HS Code | 2942000000 |
Customs
| HS Code | 2924299090 |
|---|---|
| Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Articles46
More Articles| Identification of potential pancreatic cancer serum markers: Increased sialyl-Lewis X on ceruloplasmin. Clin. Chim. Acta 442 , 56-62, (2015) Pancreatic adenocarcinoma (PDAC) usually shows an enhanced expression of sialyl-Lewis X (sLe(x)) and related epitopes. PDAC may secrete some of the proteins carrying such increased sLe(x) determinant ... | |
| Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles--part 1: separation-based methods. MAbs 7(1) , 167-79, (2015) Immunoglobulin G (IgG) crystallizable fragment (Fc) glycosylation is crucial for antibody effector functions, such as antibody-dependent cell-mediated cytotoxicity, and for their pharmacokinetic and p... | |
| Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry. MAbs 6(6) , 1474-85, (2014) CTLA4-Ig is a highly glycosylated therapeutic fusion protein that contains multiple N- and O-glycosylation sites. Glycosylation plays a vital role in protein solubility, stability, serum half-life, ac... |
Synonyms
| 2-Aminophenylformamide |
| EINECS 201-851-2 |
| Anthranilamide |
| MFCD00007981 |
| 2-Aminobenzamide |
| Benzamide, 2-amino- |
